In-Silico Structure Database (LMISSD)
BackLMISSD: Lipid Classification search results
Fatty Acyls [FA](W) --> Docosanoids [FA04] --> Neuroprostanes [FA0401]
| LM_ID | Common Name | Systematic Name | Formula | Mass |
|---|---|---|---|---|
| LMFA04010254 | ent-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010255 | ent-20-epi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010256 | ent-13,20-diepi-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010257 | ent-13,20-diepi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010258 | ent-20-epi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,5R)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010259 | 20-epi-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010260 | 13,20-diepi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010261 | 13,20-diepi-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010262 | 20-epi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010263 | 20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010264 | 13-epi-20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010265 | 13-epi-20-D4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010266 | 20-D4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010267 | ent-4-E4t-NeuroP | (R,E)-4-hydroxy-6-((1R,2S,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010268 | ent-7-epi-4-E4c-NeuroP | (R,E)-4-hydroxy-6-((1R,2R,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010269 | ent-7-epi-4-E4t-NeuroP | (R,E)-4-hydroxy-6-((1S,2S,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010270 | ent-4-E4c-NeuroP | (R,E)-4-hydroxy-6-((1S,2R,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010271 | 4-epi-4-E4c-NeuroP | (R,E)-4-hydroxy-6-((1R,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010272 | 4,7-diepi-4-E4t-NeuroP | (R,E)-4-hydroxy-6-((1R,2R,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010273 | 4,7-diepi-4-E4c-NeuroP | (R,E)-4-hydroxy-6-((1S,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010274 | 4-epi-4-E4t-NeuroP | (R,E)-4-hydroxy-6-((1S,2R,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010275 | ent-4-epi-4-E4t-NeuroP | (S,E)-4-hydroxy-6-((1R,2S,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010276 | ent-4,7-diepi-4-E4c-NeuroP | (S,E)-4-hydroxy-6-((1R,2R,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010277 | ent-4,7-diepi-4-E4t-NeuroP | (S,E)-4-hydroxy-6-((1S,2S,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010278 | ent-4-epi-4-E4c-NeuroP | (S,E)-4-hydroxy-6-((1S,2R,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010279 | 4-E4c-NeuroP | (S,E)-4-hydroxy-6-((1R,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010280 | 7-epi-4-E4t-NeuroP | (S,E)-4-hydroxy-6-((1R,2R,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010281 | 7-epi-4-E4c-NeuroP | (S,E)-4-hydroxy-6-((1S,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010282 | 4-E4t-NeuroP | (S,E)-4-hydroxy-6-((1S,2R,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010283 | ent-7-E4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2S,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010284 | ent-10-epi-7-E4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010285 | ent-10-epi-7-E4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2S,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010286 | ent-7-E4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010287 | 7-epi-7-E4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2S,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010288 | 7,10-diepi-7-E4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2R,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010289 | 7,10-diepi-7-E4c-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2S,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010290 | 7-epi-7-E4t-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2R,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010291 | ent-7-epi-7-E4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2S,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010292 | ent-7,10-diepi-7-E4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010293 | ent-7,10-diepi-7-E4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2S,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010294 | ent-7-epi-7-E4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010295 | 7-E4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2S,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010296 | 10-epi-7-E4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2R,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010297 | 10-epi-7-E4c-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2S,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010298 | 7-E4t-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2R,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid | C22H32O5 | 376.2250 |
| LMFA04010299 | ent-10-E4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010300 | ent-13-epi-10-E4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010301 | ent-13-epi-10-E4t-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010302 | ent-10-E4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |
| LMFA04010303 | 10-epi-10-E4c-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid | C22H32O5 | 376.2250 |